KOD NASDAQ
Credit Risk of going bust: higher than 73% of companies Debt: 1.7% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.26 (down 99.7%), Kodiak Sciences Inc. would be worth roughly what it owes.
Total debt $95.7M against a stock market value of $5.63B.
Distance to default 3.16 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $31.3M (short-term plus half of long-term), stock volatility 137.2%; Altman Z'' -25.29. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Palo Alto, CA 94304
US
Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting the retina. Their primary drug candidate, KSI-301, is an anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer. This compound is currently undergoing Phase IIb/III clinical trials, targeting illnesses such as wet age-related macular degeneration (AMD), diabetic macular edema, previously untreated macular edema resulting from retinal vein occlusion, and non-proliferative diabetic retinopathy. In its earlier, preclinical development pipeline, the company is also working on KSI-501, a bispecific conjugate designed for retinal conditions involving inflammation, and KSI-601, a triplet inhibitor aimed at addressing dry AMD. Established in 2009, this Palo Alto, California-based company operated under the name Oligasis, LLC before rebranding as Kodiak Sciences Inc. in September 2015.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| BORGESON JOHN A. | S-Sale | 8,514 | $87.67 | 2026-10-21 |
| BORGESON JOHN A. | S-Sale | 1,677 | $89.20 | 2026-10-21 |
| BORGESON JOHN A. | S-Sale | 7,623 | $89.74 | 2026-10-21 |
| BORGESON JOHN A. | S-Sale | 5,101 | $90.98 | 2026-10-21 |
| BORGESON JOHN A. | S-Sale | 2,985 | $91.76 | 2026-10-21 |